The Patent Finder
US

Therapeutic Use of ANTI-CS1 Antibodies

US 7,709,610 In force, term unresolved
OverviewFamilyAssignmentsSources & methods

Also listed on Facet Biotech Corporation, an earlier holder on the record. The recorded assignments below show how it moved.

Term ends no later than Aug 29, 2029 · Low confidence

In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.

Filed Nov 5, 2004 as application 10/982,357 · Granted May 4, 2010
Base term plus 844 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2004 2029
Clock starts
May 7, 2004
Ends no later than
Aug 29, 2029
Granted
May 4, 2010
base term patent term adjustment fee events Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
844
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 844 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 2 of 3 maintenance fees are paid so far. Confidence: Low. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts May 7, 2004, when application 10/842,011, the earliest non-provisional in its chain, was filed (this one was filed Nov 5, 2004)May 7, 2024High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+844 days, USPTO patent term adjustment recordAug 29, 2026High confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extension+1096 days, USPTO 35 U.S.C. 156 certificateadded to Aug 29, 2026: Aug 29, 2029High confidence
Fee eventsNo fee event states this; the fee state is read from the payments the fee record holdsIn forceMedium confidence
Computed term endThe steps above, in orderno later than Aug 29, 2029Low confidence

Partial family

Application 10/842,011Abandoned
not computed
not computed
US 7,709,610this patent
no later than Aug 2029
no later than Aug 2029
US 8,008,450Term ended
no later than May 2024
no later than May 2024
US 8,445,646Term ended
no later than May 2024
no later than May 2024
US 9,175,081Term ended
no later than May 2024
no later than May 2024
US 10,442,859Term ended
Aug 2025
Aug 2025
Partial: 2 of the 6 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Apr 29, 2005
Reel 15963, frame 875
Williams, Marna; Tso, J. Yun; Landolfi, Nicholas F.; Powers, David B; Dubridge, Robert B.; Law, Debbie; Liu, GaoProtein Design Labs, Inc.Assignment of Assignor's Interest
May 22, 2006
Reel 17655, frame 436
Protein Design Labs, Inc.PDL Biopharma, Inc.Change of Name
Feb 27, 2009
Reel 22326, frame 412
PDL Biopharma, Inc.Facet Biotech CorporationAssignment of Assignor's Interest
Oct 29, 2010
Reel 25217, frame 95
Facet Biotech CorporationAbbott Biotherapeutics Corp.Change of Name
Jan 11, 2013
Reel 29612, frame 275
Abbott Biotherapeutics Corp.AbbVie Biotherapeutics Inc.Change of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited